Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 18, 2021
Patent Application Number
16272911
Date Filed
February 11, 2019
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
